Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Creative Realities, Inc. Announces Second Quarter 2026 Earnings Release Date and Conference Call Information
-
3D Systems Announces CEO Transition Plan
-
CMS Grants New Technology Add-On Payment (NTAP) Status for ZEVASKYN®
-
Zevra Therapeutics to Present at the Canaccord Genuity Annual Growth Conference
-
Telesat secures $2.3 billion Arctic military satcom contract, expanding Telesat Lightspeed network and capacity by 44%
-
Nord Precious Metals to Present at the OTCQB Virtual Investor Conference on August 5-6th
-
Bombardier’s 4th Annual Flight Attendant Safety Summit in Montreal to Focus on Elevating Cabin Safety and Operational Excellence
-
Lead Service Line Replacement Cost Calculator Listed in the United Nations SDG Partnership Platform
-
Tecan schedules conference call on August 11th to discuss half year 2026 financial results
-
Form 8.3 - LondonMetric Property Plc
-
Dyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement
-
The Smurfs Have Arrived in Talking Tom & Friends: World
-
The Smurfs Have Arrived in Talking Tom & Friends: World
-
LEPAS Builds New Momentum in July, Advancing Global NEV Expansion
-
Microchip Technology, in Collaboration With Micron Technology, Demonstrates High-Performance PCIe® Gen 6 Storage Architecture for AI and Data Center Infrastructure
-
Superior Group of Companies Reports Second Quarter 2026 Results
-
Xometry Reports Record Second Quarter 2026 Results
-
IREN Completes Acquisition of Mirantis
-
Rhythm Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update
-
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Grey Matters Announces September Opening of its First Brain Dedicated PET Neuroimaging Clinic in the U.S.
-
NeurAxis Expands Payer Coverage with New Policies
-
Aclarion Announces Nociscan® Now Available at Goodman Campbell Brain & Spine at Ascension St. Vincent, First Site in Indiana to Offer the Technology
-
Nurix Announces $10 Million Milestone Payment Associated with Initiation of a Phase 1 Clinical Trial of a STAT6 Degrader
-
Dianthus Therapeutics Announces DNTH312, a First-In-Class, Next-Generation Bifunctional Fusion Protein Combining Claseprubart and TACI, for Severe Autoimmune Diseases
-
Encore Technologies Completes Oversubscribed Private Placement and Increases Strategic Investment in Solstar Space Company
-
Sable Announces Completion of Share Consolidation
-
Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update
-
Q2 Metals Appoints Jean-François Tremblay as Vice President – Technical Services for the Cisco Lithium Project in James Bay, Québec
-
iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1x1 Conference
-
First Watch Restaurant Group, Inc. Reports Q2 2026 Financial Results
-
Remix Therapeutics to Present at 46th Annual Canaccord Genuity Growth Conference
-
ABBYY 2026 Hackathon Winner Accelerates Mortgage Auditing Review Leveraging Document AI and Large Language Models
-
Cipher Digital Provides Second Quarter 2026 Business Update
-
Tower Semiconductor Announces Record Results for Revenue and Profitability for the Second Quarter 2026 with Third Quarter 2026 Record Revenue Guidance
-
Vantage Biosciences Completes Enrollment in Phase 2 SeeClear Study of Oral Oruvestat in Non-Proliferative Diabetic Retinopathy
-
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
-
Bioxytran Leverages Artificial Super Intelligence (ASI) to Design Broad-Spectrum Antiviral and Anti-Cancer Metastasis Drugs
-
TOP Financial Group Limited Announces Strategic Expansion to Launch Artificial Intelligence Division and Integrate Advanced AI Across Core Brokerage and FinTech Operations
-
LGI Homes, Inc. Reports Strong Second Quarter 2026 Results and Increases Full-Year 2026 Average Sales Price and Homebuilding Gross Margin Guidance Ranges
-
Strata Critical Medical Announces Second Quarter 2026 Results
-
BellRing Brands Reports Results for the Third Quarter of Fiscal Year 2026; Updates Fiscal Year 2026 Outlook
-
Certara Reports Second Quarter 2026 Financial Results
-
Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
-
Arvinas Reports Second Quarter 2026 Financial Results and Provides Corporate Update
-
Aeluma Names Jason Taylor Senior Director of Program and Project Management
-
TRISO-X Announces 70-Acre Expansion of Oak Ridge Nuclear Fuel Campus
-
TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director
-
Lisata Therapeutics Provides Update Following Termination of Merger Agreement
-
Shoals Technologies Group, Inc. Reports Financial Results for Second Quarter 2026
